You are here

Home > News & Stories > Blog

Blog

The new crop of women entrepreneurs in the BioRegion

23.06.2020

Thirty-one percent of the CEO's and founders of companies in the healthcare sector created in Catalonia since 2018 are women, a much higher percentage than in previous years. Let’s learn about these professionals who are contributing to reversing the trend.

Top 10 tips from entrepreneurs in the BioRegion

18.05.2020

More than 50 interviews with entrepreneurs and 5 years of Startup Generation make for many insights, anecdotes and experiences. We have compiled some of them in this top ten so that they can serve you as inspiration.

6 ‘made in Catalonia’ Covid-19 prediction and prognosis methods

11.05.2020

Predicting and establishing the prognosis of diseases is key to controlling them. Biocat will provide support for the 19 research projects in the BioRegion awarded €4 million from the Catalan Ministry of Health to research the pandemic, 6 of which are looking into possible prediction or...

3 Catalan Covid-19 vaccines

11.05.2020

A few days ago, the 19 research projects in the BioRegion awarded €4 million from the Catalan Ministry of Health to research the pandemic, with technical support from Biocat, were announced. Of these projects, 3 are researching potential vaccines for the SARS-CoV-2 virus. Let’s look at the...

5 existing drugs that could be used for Covid-19

08.05.2020

Five research projects in the BioRegion of Catalonia are investigating how to take advantage of therapies already in use for other diseases to treat Covid-19. They have received funding from the Catalan Ministry of Health to study this new path towards a possible cure to the pandemic. Let’s look...

Will Covid-19 affect investment in the biomedical sector?

28.04.2020

The BioRegion of Catalonia has a solid local investment fabric and the number of international investors has grown tenfold over the past 5 years. How will the pandemic affect their activity? Companies are seeing some operations postponed, but investors, for now, are optimistic: activity won’t...

Marta-Gaia Zanchi (Nina Capital): “This year we will see lower investment in health technology concentrated in fewer deals”

28.04.2020

Dr. Marta-Gaia Zanchi, founder and managing partner of Nina Capital, explains how the Covid-19 pandemic could affect investment in digital health and medical technology.

Clara Campàs (Asabys Partners): “Society’s growing interest in science due to Covid-19 could boost investment in healthcare”

27.04.2020

Clara Campàs, partner and co-founder of specialized venture capital fund Asabys Partners, analyzes how the global Covid-19 crisis is affecting the sector and is optimistic about the future of investment in healthcare.

Joël Jean-Mairet (Ysios Capital): “The Covid-19 crisis has to remind us of the need to innovate in the life sciences”

27.04.2020

Joël Jean-Mairet, managing partner of Ysios Capital, explained how he sees this crisis from the perspective of a venture capital fund and warns that continued investment in healthcare innovation is more necessary than ever.

Montserrat Vendrell (Alta Life Sciences): "Covid-19 is opening a lot of doors for business and investment opportunities in the healthcare sector”

27.04.2020

Montserrat Vendrell, partner in the Alta Life Sciences investment fund, explains how investors are experiencing the Covid-19 pandemic and highlights one of the few positives that may come out of this crisis: new opportunities in the healthcare sector.

Developed by Drauta